JP2021524485A5 - - Google Patents
Info
- Publication number
- JP2021524485A5 JP2021524485A5 JP2021500530A JP2021500530A JP2021524485A5 JP 2021524485 A5 JP2021524485 A5 JP 2021524485A5 JP 2021500530 A JP2021500530 A JP 2021500530A JP 2021500530 A JP2021500530 A JP 2021500530A JP 2021524485 A5 JP2021524485 A5 JP 2021524485A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- polypeptide
- sequence shown
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024109065A JP2024153666A (ja) | 2018-07-11 | 2024-07-05 | パラ結核症のための免疫原性組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1811382.9A GB201811382D0 (en) | 2018-07-11 | 2018-07-11 | Vaccine |
| GB1811382.9 | 2018-07-11 | ||
| PCT/GB2019/051933 WO2020012177A1 (en) | 2018-07-11 | 2019-07-10 | Immunogenic composition for paratuberculosis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024109065A Division JP2024153666A (ja) | 2018-07-11 | 2024-07-05 | パラ結核症のための免疫原性組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021524485A JP2021524485A (ja) | 2021-09-13 |
| JP2021524485A5 true JP2021524485A5 (https=) | 2022-07-12 |
Family
ID=63273113
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021500530A Pending JP2021524485A (ja) | 2018-07-11 | 2019-07-10 | パラ結核症のための免疫原性組成物 |
| JP2024109065A Pending JP2024153666A (ja) | 2018-07-11 | 2024-07-05 | パラ結核症のための免疫原性組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024109065A Pending JP2024153666A (ja) | 2018-07-11 | 2024-07-05 | パラ結核症のための免疫原性組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US12186382B2 (https=) |
| EP (1) | EP3820507A1 (https=) |
| JP (2) | JP2021524485A (https=) |
| KR (1) | KR20210033490A (https=) |
| CN (1) | CN113329765A (https=) |
| AU (1) | AU2019301899A1 (https=) |
| BR (1) | BR112021000312A2 (https=) |
| CA (1) | CA3105763A1 (https=) |
| GB (1) | GB201811382D0 (https=) |
| IL (1) | IL280070B2 (https=) |
| MA (1) | MA53131A (https=) |
| MX (1) | MX2020013924A (https=) |
| SG (1) | SG11202100120TA (https=) |
| WO (1) | WO2020012177A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201700487D0 (en) * | 2017-01-11 | 2017-02-22 | Hermon-Taylor John | Diagnostic |
| WO2026041756A1 (en) | 2024-08-21 | 2026-02-26 | Hav Vaccines Limited | Treatment of crohn's disease by mycobacterium avium subsp. paratuberculosis agent |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| GB8709803D0 (en) | 1987-04-24 | 1987-05-28 | Mcfadden J J | Treatment of crohn's disease &c |
| US5225324A (en) | 1987-04-24 | 1993-07-06 | Bioscience International, Inc. | Diagnostics for mycobacteria in public health, medical, and veterinary practice |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| CA2489769A1 (en) | 1989-03-21 | 1990-10-04 | Philip L. Felgner | Expression of exogenous polynucleotide sequences in a vertebrate |
| US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
| US5279833A (en) | 1990-04-04 | 1994-01-18 | Yale University | Liposomal transfection of nucleic acids into animal cells |
| US5283185A (en) | 1991-08-28 | 1994-02-01 | University Of Tennessee Research Corporation | Method for delivering nucleic acids into cells |
| CA2131620A1 (en) | 1992-03-20 | 1993-09-30 | Louis C. Smith | A dna transporter system and method of use |
| WO1993019768A1 (en) | 1992-04-03 | 1993-10-14 | The Regents Of The University Of California | Self-assembling polynucleotide delivery system |
| US5651981A (en) | 1994-03-29 | 1997-07-29 | Northwestern University | Cationic phospholipids for transfection |
| US5527928A (en) | 1994-09-30 | 1996-06-18 | Nantz; Michael H. | Cationic transport reagents |
| GB9526178D0 (en) | 1995-12-21 | 1996-02-21 | Taylor John Hermon | Novel polynuceotides and polypeptides in pathogenic mycobacteria and their use as diagnostics,vaccines and targets for chemotherapy |
| GB9806093D0 (en) | 1998-03-20 | 1998-05-20 | Taylor John Hermon | Diagnostics and vaccines for mycobacterial infections of animals and humans |
| US7074559B2 (en) * | 2002-03-06 | 2006-07-11 | Refents of the University of Minnesota | Mycobacterial diagnostics |
| AU2006277828B2 (en) | 2005-08-09 | 2012-02-02 | Hav Vaccines Limited | Immunogenic constructs |
| US8609097B2 (en) | 2009-06-10 | 2013-12-17 | Hoffmann-La Roche Inc. | Use of an anti-Tau pS422 antibody for the treatment of brain diseases |
| JP2013500326A (ja) | 2009-07-30 | 2013-01-07 | ファイザー バクシーンズ エルエルシー | 抗原性タウペプチドおよびその使用 |
| CA2839865A1 (en) | 2011-05-19 | 2012-11-22 | University Of Central Florida Research Foundation, Inc. | Microbe detection via hybridizing magnetic relaxation nanosensors |
| WO2014016737A1 (en) | 2012-07-24 | 2014-01-30 | Pfizer Inc. | Novel chicken monoclonal antibodies against human phosphorylated tau and uses thereof |
| US20160228528A1 (en) | 2013-01-28 | 2016-08-11 | Janssen Sciences Ireland Uc | A single or multistage mycobacterium avium subsp. paratuberculosis subunit vaccine |
| GB201700487D0 (en) * | 2017-01-11 | 2017-02-22 | Hermon-Taylor John | Diagnostic |
-
2018
- 2018-07-11 GB GBGB1811382.9A patent/GB201811382D0/en not_active Ceased
-
2019
- 2019-07-10 WO PCT/GB2019/051933 patent/WO2020012177A1/en not_active Ceased
- 2019-07-10 BR BR112021000312-6A patent/BR112021000312A2/pt unknown
- 2019-07-10 MX MX2020013924A patent/MX2020013924A/es unknown
- 2019-07-10 KR KR1020217004231A patent/KR20210033490A/ko not_active Ceased
- 2019-07-10 AU AU2019301899A patent/AU2019301899A1/en not_active Abandoned
- 2019-07-10 JP JP2021500530A patent/JP2021524485A/ja active Pending
- 2019-07-10 SG SG11202100120TA patent/SG11202100120TA/en unknown
- 2019-07-10 IL IL280070A patent/IL280070B2/en unknown
- 2019-07-10 MA MA053131A patent/MA53131A/fr unknown
- 2019-07-10 CA CA3105763A patent/CA3105763A1/en active Pending
- 2019-07-10 EP EP19752222.0A patent/EP3820507A1/en active Pending
- 2019-07-10 US US17/259,075 patent/US12186382B2/en active Active
- 2019-07-10 CN CN201980059761.5A patent/CN113329765A/zh active Pending
-
2024
- 2024-07-05 JP JP2024109065A patent/JP2024153666A/ja active Pending
- 2024-11-20 US US18/954,032 patent/US20250152691A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023518596A5 (https=) | ||
| JP2016171816A (ja) | Ｏｓｐａキメラおよびそのワクチンでの使用法 | |
| JP2008538183A5 (https=) | ||
| KR20120083899A (ko) | 마이코박테리아 백신들 | |
| JP2023528207A5 (https=) | ||
| JPWO2019156137A5 (https=) | ||
| TW200842189A (en) | DNA vaccine for Koi herpes virus (KHV) disease | |
| JP2006502702A5 (https=) | ||
| JP2021524485A5 (https=) | ||
| JP2023535121A5 (https=) | ||
| JP2018537089A5 (https=) | ||
| JP2015524802A (ja) | キメラｏｓｐａ分子を含む組成物およびその使用方法 | |
| CN109010799B (zh) | RyR2蛋白或RyR2重组蛋白在制备抗心力衰竭药物中的用途 | |
| US7531177B2 (en) | Surface protein of leptospira | |
| JP2004535161A5 (https=) | ||
| JP2005536182A (ja) | 魚由来のカセリシジンファミリーのペプチド及び核酸、及びその使用 | |
| EP2908852B1 (en) | Lyme disease vaccine | |
| JP2009504149A5 (https=) | ||
| RU2440369C2 (ru) | ГЕНЫ И БЕЛКИ Brachyspira hyodysenteriae И ИХ ПРИМЕНЕНИЕ | |
| JP5795079B2 (ja) | 細胞表面で発現される抗菌ペプチド多重合複合体 | |
| WO2012156811A2 (en) | Compositions useful for the treatment of inflammatory disease or disorders | |
| JP2024534178A5 (https=) | ||
| KR20170077252A (ko) | Hnp-1 또는 hnp-2 또는 hnp-3을 인코딩하는 플라스미드 dna, 박테리아 제조체, 진통제 (변이체) | |
| JP4520951B2 (ja) | インスリン分泌誘導剤及びインスリン分泌誘導組成物 | |
| JP2025515165A5 (https=) |